BridgeMD
Tests treatment safety and results for Mild to Moderate Dementia
Official title The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moderate Dementia
ClinicalTrials.gov ID: NCT07033468
What this study is testing
- What it's testing
- This project will explore the feasibility and efficacy of the fully immersive virtual reality leisure cognitive training tool developed by Chang Gung University in patients with mild to moderate dementia. The feasibility study will assess the feasibility and emotion-related indicators of 10 patients before and after a single training session.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Age over 55 years;
- Diagnosed with mild or moderate dementia (primarily degenerative dementia) by a consulting physician or based on past medical records;
- A score of at least 11 but no more than 23 on the Mini-Mental State Examination (MMSE);
- Has at least one family member or a regularly contacted friend (with the person's mobile number and contact at least once a week);
- Able to walk independently and complete the Timed Up \& Go (TUG) test;
You likely can't join if
- Dementia with Lewy Bodies and other dementia types resulting from specific causes, such as Huntington's Disease, substance addiction, central nervous...
- Severe health conditions that may hinder safe participation, such as respiratory distress, severe cardiovascular disease, or brain tumors.
- A psychiatric diagnosis of psychosis within the past six months.
- Diagnosis of Korsakoff syndrome.
- History of substance addiction.
- Severe hearing impairment or color blindness.
See the full eligibility criteria
- Age over 55 years;
- Diagnosed with mild or moderate dementia (primarily degenerative dementia) by a consulting physician or based on past medical records;
- A score of at least 11 but no more than 23 on the Mini-Mental State Examination (MMSE);
- Has at least one family member or a regularly contacted friend (with the person's mobile number and contact at least once a week);
- Able to walk independently and complete the Timed Up \& Go (TUG) test;
- Able to follow instructions with or without the assistance of a guardian or therapist;
- If the assessment indicates moderate dementia, further evaluation will be conducted to determine whether the participant has sufficient capacity to provide informed consent. If their capacity is found to be impaired...
- Dementia with Lewy Bodies and other dementia types resulting from specific causes, such as Huntington's Disease, substance addiction, central nervous system infections, nutritional deficiencies, and metabolic disorders.
- Severe health conditions that may hinder safe participation, such as respiratory distress, severe cardiovascular disease, or brain tumors.
- A psychiatric diagnosis of psychosis within the past six months.
- Diagnosis of Korsakoff syndrome.
- History of substance addiction.
- Severe hearing impairment or color blindness.
- History of severe vertigo or epilepsy.
- Concurrent participation in other studies that may affect cognitive function
The study team makes the final eligibility decision.
Where it's taking place
- New Taipei City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Taipei City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.